# Talzenna

NDC: 63539-295
Generic name: talazoparib
Labeler / Manufacturer: U.S. Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20181210
Marketing ended: 20270131
FDA application: NDA211651

## Active ingredients

- TALAZOPARIB TOSYLATE: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63539-295"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63539-295
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13839d4f-6acf-4ffb-a128-79df59319273